Aldesleukin for metastatic renal cell carcinoma?
D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000473:pathology / Q000556:secondary*; D002986:Clinical Trials as Topic; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000556:secondary*; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use*
D007376:Interleukin-2; D011994:Recombinant Proteins; C082598:aldesleukin